OPEN END TURBO LONG - VIRBAC Share Price

Certificat

DE000MG2HV27

Real-time Bid/Ask 06:52:43 26/06/2024 pm IST
7.9 EUR / 8.07 EUR -14.51% Intraday chart for OPEN END TURBO LONG - VIRBAC
Current month-9.14%
1 month-13.12%
Date Price Change
26/24/26 8.37 -10.39%
25/24/25 9.34 -2.91%
24/24/24 9.62 -0.31%
21/24/21 9.65 +6.04%
20/24/20 9.1 -1.41%

Delayed Quote Börse Stuttgart

Last update June 26, 2024 at 04:37 pm IST

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying VIRBAC
Issuer Morgan Stanley
WKN MG2HV2
ISINDE000MG2HV27
Date issued 17/04/2024
Strike 252.8
Maturity Unlimited
Parity 10 : 1
Emission price 10.8
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 12.6
Lowest since issue 8.3
Spread 0.17
Spread %2.11%

Company Profile

Virbac specializes in the research, production and marketing of veterinary medicines. The activity is organized around 2 product families: - pet medications: pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds, rodents, etc. The group also offers foods and electronic identification chips; - livestock medications: pest control drugs and antibiotics intended for cattle, sheep, pigs, poultry, etc. Net sales are distributed geographically as follows: France (15.4%), Europe (26.2%), Latin America (17.1%), Asia (16.4%), North America (13.2%), Pacific (9.3%), Africa and Middle East (2.4%).
Sector
-
More about the company

Ratings for Virbac

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Virbac

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
335 EUR
Average target price
373.3 EUR
Spread / Average Target
+11.44%
Consensus